RxDoctor Payments DataLook up a doctor →

Rikki Racela, MD

Neurology · Englewood, NJNPI 1023218096

Payments from drug & device makers

$138,662in general payments, 2019–2025

Across 2,355 payments — averaging $58.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$47K
  • Neurocrine Biosciences, Inc.$24K
  • SK Life Science, Inc.$10K
  • EMD Serono, Inc.$6K
  • Teva Pharmaceuticals USA, Inc.$6K
  • E.r. Squibb & Sons, L.L.C.$4K
  • plus $41K from 54 others
$1,200in research payments, 2019–2025

Across 2 payments — averaging $600.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Avanir Pharmaceuticals, Inc.$1K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)329$47,214
Neurocrine Biosciences, Inc.103$24,351
SK Life Science, Inc.177$9,859
EMD Serono, Inc.100$5,663
Teva Pharmaceuticals USA, Inc.327$5,639
E.r. Squibb & Sons, L.L.C.22$3,929
Biogen117$3,715
Novartis77$3,261
Acadia Pharmaceuticals Inc82$2,521
Amgen(2 entities)44$2,379
Bristol Myers Squibb63$2,195
Lundbeck LLC77$1,905
AstraZeneca(2 entities)55$1,788
Sarepta Therapeutics, Inc.1$1,500
Genentech USA, Inc.33$1,333
Lilly USA, LLC58$1,302
Jazz Pharmaceuticals Inc.37$1,087
Avadel CNS Pharmaceuticals, LLC32$1,077
Otsuka America Pharmaceutical, Inc.21$980
Argenx US, Inc.43$939
Eisai Inc.28$936
Pfizer77$859
Sanofi13$848
Harmony Biosciences LLC40$847
TG Therapeutics, Inc.14$844
Biohaven Pharmaceuticals, Inc.21$833
UCB, Inc.31$759
CSL Behring31$724
Axsome Therapeutics, Inc.19$718
Medtronic(3 entities)10$692
Biohaven Pharmaceutical Holding Company Ltd.16$664
Johnson & Johnson(2 entities)17$662
MDD US Operations, LLC15$434
Vertex2$387
Boston Scientific5$378
Neurelis, Inc.12$366
Microtransponder, Inc.1$358
Kyowa Kirin, Inc.13$316
Alnylam Pharmaceuticals Inc.13$308
W. L. Gore & Associates, Inc.10$271
Ambu A/s1$250
Acorda Therapeutics, Inc10$247
Livanova USA, Inc.2$245
Greenwich Biosciences, Inc.6$212
Aucta Pharmaceuticals, Inc.17$210
Abbott4$207
Vanda Pharmaceuticals Inc.6$185
Upsher-smith Laboratories LLC15$185
Banner Life Sciences, LLC3$156
Adamas Pharmaceuticals, Inc.11$149
Novartis Gene Therapies, Inc. (fka Avexis, Inc.)1$135
Azurity Pharmaceuticals, Inc.8$135
Merz Pharmaceuticals, LLC7$126
Aquestive Therapeutics, Inc.8$113
Grifols USA, LLC7$112
Penumbra, Inc.1$96
Arbor Pharmaceuticals, Inc.6$86
Impel Pharmaceuticals Inc.1$84
GE HealthCare4$76
Catalyst Pharmaceuticals, Inc.3$69

How this compares

$138,662 in reported general payments places this provider in the 90th percentile of 521 neurology providers in New Jersey.

See all neurology providers in New Jersey →

Medicare billing

Part B allowed, 2024
$292,062
Medicare patients
887
Services billed
5,283

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Englewood

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →